People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Renova Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $167K | $739K | 2024 |
Morgan Xu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Morgan Xu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Torres | 1 | 5 |
| Roy Cosan | 1 | 2 |
| William Davidson | 1 | 2 |
| Shawn Swaney | 1 | 2 |
| Vijay Mahant | 1 | 1 |
| Pierre Lecocq | 1 | 1 |
| Kirk Hammond | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.